elliptinium has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homma, M; Nagasawa, H; Namiki, H; Niki, K | 1 |
| Buchet, P; Dadoun, C; Ducastelle, T; Fillastre, JP; Raguenez-Viotte, G | 1 |
2 other study(ies) available for elliptinium and Body Weight
| Article | Year |
|---|---|
Inhibition by hydroxy-N-methyl elliptinium of precancerous mammary hyperplastic alveolar nodule formation in mice.
Topics: Alkaloids; Animals; Antineoplastic Agents; Body Weight; Ellipticines; Endocrine Glands; Estrus; Female; Hyperplasia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Organ Size; Precancerous Conditions; Pregnancy; Prolactin | 1984 |
Renal toxicity of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate in the Wistar rat.
Topics: Alkaloids; Animals; Antineoplastic Agents; Body Weight; Ellipticines; Female; Glycerol; Kidney; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Lipid Metabolism; Organ Size; Phospholipids; Rats; Rats, Inbred Strains | 1988 |